Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.

نویسندگان

  • Priscilla K Brastianos
  • Scott L Carter
  • Sandro Santagata
  • Daniel P Cahill
  • Amaro Taylor-Weiner
  • Robert T Jones
  • Eliezer M Van Allen
  • Michael S Lawrence
  • Peleg M Horowitz
  • Kristian Cibulskis
  • Keith L Ligon
  • Josep Tabernero
  • Joan Seoane
  • Elena Martinez-Saez
  • William T Curry
  • Ian F Dunn
  • Sun Ha Paek
  • Sung-Hye Park
  • Aaron McKenna
  • Aaron Chevalier
  • Mara Rosenberg
  • Frederick G Barker
  • Corey M Gill
  • Paul Van Hummelen
  • Aaron R Thorner
  • Bruce E Johnson
  • Mai P Hoang
  • Toni K Choueiri
  • Sabina Signoretti
  • Carrie Sougnez
  • Michael S Rabin
  • Nancy U Lin
  • Eric P Winer
  • Anat Stemmer-Rachamimov
  • Matthew Meyerson
  • Levi Garraway
  • Stacey Gabriel
  • Eric S Lander
  • Rameen Beroukhim
  • Tracy T Batchelor
  • Jose Baselga
  • David N Louis
  • Gad Getz
  • William C Hahn
چکیده

UNLABELLED Brain metastases are associated with a dismal prognosis. Whether brain metastases harbor distinct genetic alterations beyond those observed in primary tumors is unknown. We performed whole-exome sequencing of 86 matched brain metastases, primary tumors, and normal tissue. In all clonally related cancer samples, we observed branched evolution, where all metastatic and primary sites shared a common ancestor yet continued to evolve independently. In 53% of cases, we found potentially clinically informative alterations in the brain metastases not detected in the matched primary-tumor sample. In contrast, spatially and temporally separated brain metastasis sites were genetically homogenous. Distal extracranial and regional lymph node metastases were highly divergent from brain metastases. We detected alterations associated with sensitivity to PI3K/AKT/mTOR, CDK, and HER2/EGFR inhibitors in the brain metastases. Genomic analysis of brain metastases provides an opportunity to identify potentially clinically informative alterations not detected in clinically sampled primary tumors, regional lymph nodes, or extracranial metastases. SIGNIFICANCE Decisions for individualized therapies in patients with brain metastasis are often made from primary-tumor biopsies. We demonstrate that clinically actionable alterations present in brain metastases are frequently not detected in primary biopsies, suggesting that sequencing of primary biopsies alone may miss a substantial number of opportunities for targeted therapy.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

P 115: Potential Therapeutic Targets Related to Neuroinflammation in Treatment and Prevention of Autism

Autism spectrum disorder (ASD) is a mental condition, present from early childhood, characterized by great difficulty in communicating and forming relationships with others and using language. In the last four decades many studies have shown that immune responses in different regions of brain play an important role in ASD pathogenicity. A conservative estimate based on the research suggests tha...

متن کامل

Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics

Breast cancer brain metastases remain a significant clinical problem. Chemotherapy is ineffective and a lack of treatment options result in poor patient outcomes. Targeted therapeutics have proven to be highly effective in primary breast cancer, but lack of molecular genomic characterization of metastatic brain tumors is hindering the development of new treatment regimens. Here we contribute to...

متن کامل

Clonal evolution of glioblastoma under therapy. - PubMed - NCBI

Glioblastoma (GBM) is the most common and aggressive primary brain tumor. To better understand how GBM evolves, we analyzed longitudinal genomic and transcriptomic data from 114 patients. The analysis shows a highly branched evolutionary pattern in which 63% of patients experience expression-based subtype changes. The branching pattern, together with estimates of evolutionary rate, suggests tha...

متن کامل

Papillary thyroid cancer with metastases to brain, lung and kidney: A case of dosimetry proven privilege of surgical resection of organ metastases

A 45-year-old woman presented with a headache and visual complaints. Brain MRI revealed a large mass in the right occipital cortex. The tumor was surgically removed and pathological examination showed papillary carcinoma originating from thyroid gland. She had a history of thyroid surgery 27 years ago indicating papillary thyroid cancer with central neck lymph node involvement followed by no ad...

متن کامل

Dissection of the Process of Brain Metastasis Reveals Targets and Mechanisms for Molecular-based Intervention.

Brain metastases outnumber the incidence of brain tumors by a factor of ten. Patients with brain metastases have a dismal prognosis and current treatment modalities achieve only a modest clinical benefit. We discuss the process of brain metastasis with respect to mechanisms and involved targets to outline options for therapeutic intervention and focus on breast and lung cancer, as well as melan...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Cancer discovery

دوره 5 11  شماره 

صفحات  -

تاریخ انتشار 2015